After phase 3 fail, Biogen posts 12-month data cut to make case for ALS prospect

After phase 3 fail, Biogen posts 12-month data cut to make case for ALS prospect ntaylor Fri, 06/03/2022 - 07:11... Read more

Bron:

FierceBiotech